Prognostic impact, concurrent genetic mutations, and gene expression features of AML with CEBPA mutations in a cohort of 1182 cytogenetically normal AML patients: further evidence for CEBPA double mutant AML as a distinctive disease entity (Q82992297)
Jump to navigation
Jump to search
scientific article published on 21 December 2010
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Prognostic impact, concurrent genetic mutations, and gene expression features of AML with CEBPA mutations in a cohort of 1182 cytogenetically normal AML patients: further evidence for CEBPA double mutant AML as a distinctive disease entity |
scientific article published on 21 December 2010 |
Statements
Prognostic impact, concurrent genetic mutations, and gene expression features of AML with CEBPA mutations in a cohort of 1182 cytogenetically normal AML patients: further evidence for CEBPA double mutant AML as a distinctive disease entity (English)
Lars Bullinger
Andrea Corbacioglu
Mathijs A Sanders
Claudia A J Erpelinck
Bas J Wouters
Sonja C van der Poel-van de Luytgaarde
Frederik Damm
Jürgen Krauter
Arnold Ganser
Richard F Schlenk
Bob Löwenberg
Ruud Delwel
Hartmut Döhner
Peter J M Valk
Konstanze Döhner
21 December 2010